Table 2 Comparison of the vital indicators between before and after REBOA

Systolic blood pressure (mmHg)

61 (57–77)

111 (90–126)*

Heart rate (beat/min)

126 (112–131)

123 (113–127)

White blood cells (/μL)

12100 (11050–14250)

16600 (13950–17900)

Hemoglobin (g/dL)

7.3 (5.4–10)

9.7 (8.7–10.6)

Platelet (×10⁴/μL)

17.3 (12.1–35.3)

10.3 (7.2–13.6)

Prothrombin time (%)

64 (57–94)

56 (50–70)

Lactate (mmol/L)

3.2 (2.9–6.0)

5.4 (4.3–7.0)

Base excess (mmol/L)

−11.5 (−14.6 - –8.7)

−3.1 (−4.8 - –1.4)

Blood urea nitrogen (mg/dL)

21.1 (16.3–45.5)

30.8 (16.6–38.8)

Creatinine (mg/dL)

0.97 (0.90–1.03)

1.14 (0.83–1.29)

Aspartate transaminase (U/L)

14 (11.5–43.5)

101 (64.5–608)

Total bilirubin (mg/dL)

0.40 (0.35–0.6)

0.60 (0.45–0.80)

Potassium (mmol/L)

4.0 (3.8–4.1)

3.5 (3.5–4.2)

Sodium (mmol/L)

138 (135–139)

137 (136–141)

Creatine kinase (U/L)

56 (47–80)

263 (109–620)

Alkaline phosphatase (U/L)

191 (153–197)

137 (104–249)

Lactate dehydrogenase (U/L)

158 (123–285)

411 (328–862)*

C reactive protein (mg/dL)

1.61 (0.55–2.64)

1.07 (0.70–3.55)